CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $6.87M invested in Cellectar Biosciences in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$193K

Top Sellers

1
-$224K
2
-$88.2K
3
-$33K
4
Morgan Stanley
Morgan Stanley
New York
-$6K
5
SM
Sabby Management
Florida
-$274
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.38M
2
$1.64M
3
$441K
4
$193K
5
$133K
6
$44K
7
$29K
8
$3K
9
$2K
10
$1.92K
11
$1K
12
$15
13
–
14
–